Scientists in a new study detected spike protein in the bloodstream of people with long COVID two months after infection and COVID-19 vaccination, suggesting spike protein may persist in the body much longer than previously thought and does not remain at the injection site. The paper, published Dec. 27 in the European Review for Medical […]
Research Studies
Study Shows Fourth Vaccine Dose Increased Risk of COVID Death by 24 Percent
A fourth dose of the COVID-19 vaccine may not be as effective as expected, according to a recent peer-reviewed study. The retrospective population-based observational study published in the European Journal of Clinical Investigation used national health data from the Austrian epidemiological reporting system, individual all-cause mortality data from Statistics Austria, and the national COVID-19 vaccine […]
FDA Acknowledges COVID Vaccine Safety Signal for Seizures Among Toddlers
A new safety signal associated with mRNA COVID-19 vaccination has been detected by the U.S. Food and Drug Administration (FDA) among toddlers, prompting calls for further evaluation and more robust studies. According to a preprint study published Oct. 15 on medRxiv, a statistical signal was detected for seizures/convulsions in children aged 2 to 4 who […]
Pfizer Used ‘Healthy Vaccinee Bias’ to Inflate Efficacy of COVID-19 Vaccine
In a recent Letter to the Editor published in the New England Journal of Medicine (NEJM), epidemiologist Dr. Tracy Høeg, physician-scientist Dr. Vinay Prasad, and Dr. Ram Duriseti from Stanford School of Medicine stated that a 2021 Israeli study on Pfizer’s COVID-19 booster may have overestimated the vaccine’s effectiveness by concluding those who received a booster had 90 percent lower […]
Forensic Analysis of Deaths in Pfizer’s mRNA Vaccine Trial Reveals Significant Inconsistencies
A group of researchers are calling Pfizer’s and BioNTech’s early trial data on its original COVID-19 vaccine into question after a forensic analysis revealed significant inconsistencies between data in the companies’ six-month interim report and publications authored by Pfizer/BioNTech trial site administrators. The preprint, published on Sept. 4, showed trial subjects vaccinated with Pfizer’s COVID-19 vaccine experienced a 3.7 […]